INPUT: Information Needs Around Parenteral nUTrition in Cancer

Sponsor
Royal Marsden NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT04495530
Collaborator
St George's University Hospitals NHS Foundation Trust (Other), University College London Hospitals (Other), University of Southampton (Other), London North West Healthcare NHS Trust (Other)
12
4
17.3
3
0.2

Study Details

Study Description

Brief Summary

This study will explore the information needs of patient's with advanced cancer, and their carers, when making a decision to commence or discontinue parenteral nutrition. Interviews will be conducted with both patients with advanced cancer, and their carers to determine the information they need to make a shared decision with the healthcare team.

Condition or Disease Intervention/Treatment Phase
  • Other: Non-interventional study

Detailed Description

Parenteral nutrition (PN) is a type of nutritional liquid that is given directly into a vein, and is usually given when a person does not have a working gut. This type of nutrition is managed by a team of healthcare professionals and requires regular monitoring, such as bloods tests, to allow the team to provide the right balance of nutrients to the individual patient. This is an important decision, and the benefits, risks and consequences of having this type of nutrition should be fully explained to the patient and carer, to make sure they can make an informed decision. The aim of this study is to find out what information both patients and carers feel they need to be able to make a decision to start, and a later date stop, parenteral nutrition, with a diagnosis of advanced (incurable) cancer.

It is not clear if patients and carers get all the information they need before making this decision, and often the decision is made by a doctor and other healthcare professionals. However, patients and carers have a right to make decisions about their care. We will therefore interview patients and carers who have experience of making this decision, or in the process of making this decision, to find out what information is important to them. Our aim is to use the results from this research to improve the experience that patients and carers have in the future.

Study Design

Study Type:
Observational
Actual Enrollment :
12 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
What Information do Patients and Carers Need to Make an Informed Decision to Commence and Discontinue Parenteral Nutrition, in Advanced Cancer?
Actual Study Start Date :
Jan 19, 2021
Actual Primary Completion Date :
Jun 30, 2022
Actual Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Patient

Patients will be considering commencing or discontinuing parenteral nutrition, or will be receiving home parenteral nutrition

Other: Non-interventional study
semi-structured interviews will take place on one occasion with participants in this study. This is qualitative research, and does not involve any interventions

Carer

Carers will be those caring for a patient with advanced cancer who is considering commencing or discontinuing parenteral nutrition, or already receiving parenteral nutrition. Carers will also be recruited if they previously cared for a person with advanced cancer receiving parenteral nutrition in the last 12 months

Other: Non-interventional study
semi-structured interviews will take place on one occasion with participants in this study. This is qualitative research, and does not involve any interventions

Outcome Measures

Primary Outcome Measures

  1. The type of information that patients and carers need to make an informed decision to commence or discontinue parenteral nutrition [Through completion of study; expected 1 year]

    This exploratory study will provide insight into the information that patients with advanced cancer, and their carers need to make an informed decision to commence and discontinue parenteral nutrition

Secondary Outcome Measures

  1. How healthcare professionals should deliver information to patients and carers in order for them to make an informed decision to commence or discontinue parenteral nutrition [Through completion of study; expected 1 year]

    Patients and carers will provide insight into how they would like to receive information regarding parenteral nutrition from the clinical team. This may be through verbal or written communication.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adults aged 18 years and over

  • Fluent English speaker

  • Is aware of diagnosis of advanced cancer

  • Patient considering starting PN, is currently receiving PN or has previously received PN OR

  • Carer of a patient considering, receiving or who has received PN

  • NHS patient

  • Assessed as having capacity to give consent and participate

  • Current patient at one of the recruiting hospital sites

Exclusion Criteria:
  • Private patients

Contacts and Locations

Locations

Site City State Country Postal Code
1 St Mark's Hospital London United Kingdom HA1 3UJ
2 University College London Hospitals NHS Foundation Trust London United Kingdom NW1 2BU
3 St George's NHS Foundation Trust London United Kingdom SW17 0QT
4 Royal Marsden Hospital NHS Foundation Trust London United Kingdom SW3 6JJ

Sponsors and Collaborators

  • Royal Marsden NHS Foundation Trust
  • St George's University Hospitals NHS Foundation Trust
  • University College London Hospitals
  • University of Southampton
  • London North West Healthcare NHS Trust

Investigators

  • Principal Investigator: Clare Shaw, Royal Marsden NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Royal Marsden NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04495530
Other Study ID Numbers:
  • CCR 5217
First Posted:
Aug 3, 2020
Last Update Posted:
Jul 15, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 15, 2022